Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 19, 2024 08:00 ET | Source: Biolojic Design

Biolojic Design Joins Johnson & Johnson Innovation - JLABS

Biolojic Design expands U.S. presences by becoming a resident company at Johnson & Johnson JLABS DC
May 09, 2023 08:30 ET | Source: Feel Therapeutics

Feel Therapeutics Selected to Join Johnson & Johnson Innovation–JLABS to Catalyze their Vision of Digital Precision Medicine in Mental Health

SAN FRANCISCO, May 09, 2023 (GLOBE NEWSWIRE) -- Feel Therapeutics, a leading digital precision medicine company, is proud to announce that it has been accepted into Johnson & Johnson...
June 25, 2018 08:00 ET | Source: BIOLIFE4D Corporation

BIOLIFE4D Successfully Demonstrates Ability to 3D Bioprint Human Cardiac Tissue

CHICAGO, June 25, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully...
May 29, 2018 08:02 ET | Source: BIOLIFE4D Corporation

BIOLIFE4D Establishes Operations in Houston as Part of Commercialization Strategy for Life-Saving 3D Bioprinting Technology

CHICAGO, May 29, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it is now a resident...
May 24, 2018 11:00 ET | Source: Amarantus Bioscience Holdings, Inc.

Amarantus to Present at LD Micro and The Reg A Conference

NEW YORK, May 24, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc. (OTCPink:AMBS) (the "Company," or AMBS), a US-based JLABS-alumnus biotechnology holding company,...
May 11, 2018 10:25 ET | Source: Amarantus Bioscience Holdings, Inc.

Amarantus Provides Business Overview

NEW YORK, May 11, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company," or AMBS), a US-based JLABS-alumnus biotechnology holding company,...
April 05, 2018 08:00 ET | Source: Amarantus Bioscience Holdings, Inc.

Amarantus Appoints Barney Monte as Interim COO/CFO and Promotes Brian Harvey to Chief Regulatory Advisor

NEW YORK, April 05, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company" or AMBS), a US-based JLABS-alumnus biotechnology holding company,...